MedicalDevice Licensing.com
Innovaro Pharmalicensing
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Innovaro Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Pay-per-Click New!
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Innovaro Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Innovaro Pharmalicensing
is a division of
Innovaro Europe Ltd
Innovaro Corporation
Out-licensing

ARTIFICIAL TISSUE FOR TRANSPLANTATION OR CLINICAL SCREENING

Fundación Progreso y Salud
New method of preparation of artificial tissues. These are very similar to the natural ones from the point of view of structure and functionality.may be used to increase, restore or replace the functional activity of a tissue or organ which is damaged.

Full description

Tissue engineering is a collection of techniques that enable the in vitro manufacture of artificial tissues. It is based on cell culture from stem cells, the creation of extracellular matrices and the obtention of growth factors and cell differentiation factors. Most of the models developed for the creation of artificial tissues use different kinds of biomaterials such as collagen type I, fibroin, fibrin, chitosan, polyglicolyc acid, or fibrin with agarose. However, the hitherto existing artificial tissues have limitations such as difficult manipulation, unsatisfactory functionality, biocompatibility problems, loss of volume, etc. Therefore, it is necessary to develop new techniques for the production of artificial tissues that may be used for replacing or restoring damaged tissues or organs, as well as in the assessment of drug and chemical products.

 

Through this method, our group has prepared artificial skin, oral mucose, cornea, urethra and bladder. In particular, artificial skin has been successfully tested in vivo on mice.

Advantages of the offer

The innovation of the present offer lies on the use of a matrix of fibrin and a polysaccaride (e.g. agarose) for the culture of the artificial tissue, followed by a final step of partial dehydration. The products thus obtained exhibit optimal levels of consistency and elasticity and a show a structure and functionality very similar to those of the corresponding natural tissues.

The characterizing features of this method are the culture of the tissue in a matrix comprising fibrin and agarose and a final step of partial dehydration of the resulting product. This final step induces a nanostructuration of the tissue which renders it highly similar to the natural one and provides it with optimal levels of consistency and elasticity. The method allows the production of tissues for autologous, allogenic and xenogenic transplantation.

Domain of application

The invention finds application in the field of tissue engineering. In particular, it is suitable for the production of artificial tissues for replacing or restoring damaged tissues or organs (skin, oral mucose, cornea, urethra, bladder, etc.), as well as for the assessment of drug and chemical products.

Development status

Early Stage

Type of business relationship sought

The group is looking for a collaboration for further development or for a licence agreement.

Patent number

IPR-Data : P200930625

Licensing contact

Gustavo Fúster Olagibel
Director
OTT-SSPA

Contact directly

Company details

Fundación Progreso y Salud

The Fundación Progreso y Salud is the central entity which supports and manages Public Health System research in Andalusia and also effectively promotes health research and innovation in the region.

View profile

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Related items

Related categories

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioTrinity
Press releases: Innovaro Pharmalicensing current industry press releases.

© Copyright 1998-2010 Innovaro Pharmalicensing, a division of Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us